Q9H0H5 (RGAP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 115.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Rac GTPase-activating protein 1 Alternative name(s): Male germ cell RacGap Short name=MgcRacGAP Protein CYK4 homolog Short name=CYK4 Short name=HsCYK-4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 632 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Plays key roles in controlling cell growth and differentiation of hematopoietic cells through mechanisms other than regulating Rac GTPase activity. Also involved in the regulation of growth-related processes in adipocytes and myoblasts. May be involved in regulating spermatogenesis and in the RACGAP1 pathway in neuronal proliferation. Shows strong GAP (GTPase activation) activity towards CDC42 and RAC1 and less towards RHOA. Essential for the early stages of embryogenesis. May play a role in regulating cortical activity through RHOA during cytokinesis. May participate in the regulation of sulfate transport in male germ cells. Ref.1 Ref.7 Ref.8 Ref.9 Ref.10 Ref.13 Ref.15 Ref.16 Ref.17 Ref.19 Ref.23 Ref.24 |
| Subunit structure | Heterotetramer of two molecules each of RACGAP1 and KIF23. Found in the centralspindlin complex composed of RACGAP1 and KIF23. Associates with alpha-, beta- and gamma-tubulin and microtubules. Interacts via its Rho-GAP domain with RND2. Associates with AURKB during M phase. Interacts via its Rho-GAP domain and basic region with PRC1. The interaction with PRC1 inhibits its GAP activity towards CDC42 in vitro, which may be required for maintaining normal spindle morphology. Interacts with SLC26A8 via its N-terminus. Interacts with RAB11FIP3. Interacts with ECT2; the interaction is direct, occurs at anaphase and during cytokinesis in a microtubule-dependent manner and is enhanced by phosphorylation by PLK1. Interacts with KIF23; the interaction is direct. Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.14 Ref.16 Ref.17 Ref.19 Ref.21 Ref.24 |
| Subcellular location | Nucleus. Cytoplasm. Cytoplasm › cytoskeleton › spindle. Cytoplasmic vesicle › secretory vesicle › acrosome. Cleavage furrow. Midbody. Note: Colocalizes with RND2 in Golgi-derived proacrosomal vesicles and the acrosome By similarity. During interphase, localized to the nucleus and cytoplasm along with microtubules, in anaphase, is redistributed to the central spindle and, in telophase and cytokinesis, to the midbody. Colocalizes with RHOA at the myosin contractile ring during cytokinesis. Colocalizes with ECT2 to the mitotic spindles during anaphase/metaphase, the cleavage furrow during telophase and at the midbody at the end of cytokinesis. Colocalizes with Cdc42 to spindle microtubules from prometaphase to telophase. Ref.8 Ref.11 Ref.15 Ref.16 Ref.17 Ref.19 Ref.23 Ref.24 |
| Tissue specificity | Highly expressed in testis, thymus and placenta. Expressed at lower levels in spleen and peripheral blood lymphocytes. In testis, expression is restricted to germ cells with the highest levels of expression found in spermatocytes. Expression is regulated in a cell cycle-dependent manner and peaks during G2/M phase. Ref.1 Ref.7 Ref.9 Ref.11 |
| Induction | Expression is down-regulated during macrophage differention of HL-60 cells. Ref.1 |
| Domain | The coiled coil region is indispensible for localization to the midbody during cytokinesis. Ref.8 |
| Post-translational modification | Phosphorylated at multiple sites in the midbody during cytokinesis. Phosphorylation by AURKB on Ser-387 at the midbody is, at least in part, responsible for exerting its latent GAP activity towards RhoA. Phosphorylation on multiple serine residues by PLK1 enhances its association with ECT2 and is critical for cleavage furrow formation. Ref.12 Ref.23 Ref.24 |
| Sequence similarities | Contains 1 phorbol-ester/DAG-type zinc finger. Contains 1 Rho-GAP domain. |
| Sequence caution | The sequence AAH24144.1 differs from that shown. Reason: Frameshift at positions 171, 205 and 437. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| SLC26A8 | Q96RN1 | 2 | EBI-717233,EBI-1792052 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 632 | 632 | Rac GTPase-activating protein 1 | PRO_0000228808 | ||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 349 – 539 | 191 | Rho-GAP | |||||||||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 286 – 335 | 50 | Phorbol-ester/DAG-type | |||||||||||||||||||||||||||||||||||||||||||||||
| Region | 106 – 285 | 180 | Interaction with SLC26A8 | |||||||||||||||||||||||||||||||||||||||||||||||
| Coiled coil | 53 – 110 | 58 | Potential | |||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 149 | 1 | Phosphoserine; by PLK1 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 154 | 1 | Phosphoserine Ref.25 Ref.26 Ref.28 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 157 | 1 | Phosphoserine; by PLK1 Ref.23 Ref.24 Ref.25 Ref.26 Ref.28 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 161 | 1 | Phosphothreonine Ref.18 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 164 | 1 | Phosphoserine; by PLK1 Ref.18 Ref.23 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 170 | 1 | Phosphoserine; by PLK1 Ref.23 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 203 | 1 | Phosphoserine Ref.18 Ref.20 Ref.22 Ref.25 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 206 | 1 | Phosphoserine Ref.22 Ref.25 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 214 | 1 | Phosphoserine Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 257 | 1 | Phosphoserine Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 260 | 1 | Phosphothreonine Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 342 | 1 | Phosphothreonine Ref.22 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 387 | 1 | Phosphoserine; by AURKB Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 410 | 1 | Phosphoserine; by AURKB Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 567 | 1 | Phosphothreonine Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 580 | 1 | Phosphothreonine Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 588 | 1 | Phosphothreonine Ref.20 Ref.22 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 600 | 1 | Phosphoserine Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 601 | 1 | Phosphothreonine Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 606 | 1 | Phosphothreonine Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 149 | 1 | S → A: Does not inhibit interaction with ECT2. Reduces strongly phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-170. Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 157 | 1 | S → A: Does not inhibit interaction with ECT2. Reduces strongly phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-164 and A-170. Reduces strongly phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-164; A-170 and A-214. Ref.23 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 164 | 1 | S → A: Does not inhibit interaction with ECT2. Reduces strongly phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-157 and A-170. Reduces strongly phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-170 and A-214. Ref.23 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 170 | 1 | S → A: Does not inhibit interaction with ECT2. Reduces strongly phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-157 and A-164. Reduces strongly phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-214. Ref.23 Ref.24 | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 214 | 1 | S → A: Reduces strongly phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-170. Ref.23 | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 385 | 1 | R → A: Abolishes GAP activity towards RAC1. Abolishes GAP activity towards CDC42 in prometaphase. Induces multiple blebs during cytokinesis. Ref.1 Ref.13 Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 155 | 1 | D → H in BAA91347. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 518 | 1 | L → S in BAA90247. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 289 – 293 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 301 – 303 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 312 – 320 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 325 – 330 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 351 – 354 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 357 – 360 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 364 – 376 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 377 – 379 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 381 – 385 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 390 – 401 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 409 – 411 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 415 – 427 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 429 – 431 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 436 – 438 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 439 – 447 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 451 – 463 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 467 – 485 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 493 – 504 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 508 – 511 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 514 – 533 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 536 – 540 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 541 – 543 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "MgcRacGAP is involved in the control of growth and differentiation of hematopoietic cells." Kawashima T., Hirose K., Satoh T., Kaneko A., Ikeda Y., Kaziro Y., Nosaka T., Kitamura T. Blood 96:2116-2124(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, MUTAGENESIS OF ARG-385, INDUCTION. |
| [2] | "Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W., Ottenwaelder B., Obermaier B. Poustka A.Genome Res. 11:422-435(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Hepatoma. |
| [4] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Placenta and Testis. |
| [6] | "Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O. DNA Res. 7:143-150(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 63-632. Tissue: Brain. |
| [7] | "MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells." Toure A., Dorseuil O., Morin L., Timmons P., Jegou B., Reibel L., Gacon G. J. Biol. Chem. 273:6019-6023(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 106-632, FUNCTION, TISSUE SPECIFICITY. Tissue: Placenta. |
| [8] | "MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody." Hirose K., Kawashima T., Iwamoto I., Nosaka T., Kitamura T. J. Biol. Chem. 276:5821-5828(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, DOMAIN. |
| [9] | "Tat1, a novel sulfate transporter specifically expressed in human male germ cells and potentially linked to rhogtpase signaling." Toure A., Morin L., Pineau C., Becq F., Dorseuil O., Gacon G. J. Biol. Chem. 276:20309-20315(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SLC26A8, TISSUE SPECIFICITY. |
| [10] | "Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity." Mishima M., Kaitna S., Glotzer M. Dev. Cell 2:41-54(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE CENTRALSPINDLIN COMPLEX, ASSOCIATION TO MICROTUBULES, INTERACTION WITH KIF23. |
| [11] | "Rho family GTPase Rnd2 interacts and co-localizes with MgcRacGAP in male germ cells." Naud N., Toure A., Liu J., Pineau C., Morin L., Dorseuil O., Escalier D., Chardin P., Gacon G. Biochem. J. 372:105-112(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RND2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [12] | "Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis." Minoshima Y., Kawashima T., Hirose K., Tonozuka Y., Kawajiri A., Bao Y.C., Deng X., Tatsuka M., Narumiya S., May W.S. Jr., Nosaka T., Semba K., Inoue T., Satoh T., Inagaki M., Kitamura T. Dev. Cell 4:549-560(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH AURKB, PHOSPHORYLATION AT SER-387 AND SER-410. |
| [13] | "MgcRacGAP regulates cortical activity through RhoA during cytokinesis." Lee J.S., Kamijo K., Ohara N., Kitamura T., Miki T. Exp. Cell Res. 293:275-282(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ARG-385. |
| [14] | "Human mitotic spindle-associated protein PRC1 inhibits MgcRacGAP activity toward Cdc42 during the metaphase." Ban R., Irino Y., Fukami K., Tanaka H. J. Biol. Chem. 279:16394-16402(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PRC1. |
| [15] | "Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis." Oceguera-Yanez F., Kimura K., Yasuda S., Higashida C., Kitamura T., Hiraoka Y., Haraguchi T., Narumiya S. J. Cell Biol. 168:221-232(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-385. |
| [16] | "An ECT2-centralspindlin complex regulates the localization and function of RhoA." Yuce O., Piekny A., Glotzer M. J. Cell Biol. 170:571-582(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ECT2 AND KIF23, SUBCELLULAR LOCATION. |
| [17] | "MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis." Zhao W.-M., Fang G. Proc. Natl. Acad. Sci. U.S.A. 102:13158-13163(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ECT2, SUBCELLULAR LOCATION. |
| [18] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161; SER-164 AND SER-203, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Dissecting the role of Rho-mediated signaling in contractile ring formation." Kamijo K., Ohara N., Abe M., Uchimura T., Hosoya H., Lee J.S., Miki T. Mol. Biol. Cell 17:43-55(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE CENTRALSPINDLIN COMPLEX, INTERACTION WITH ECT2 AND KIF23, SUBCELLULAR LOCATION. |
| [20] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND THR-588, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "Sequential Cyk-4 binding to ECT2 and FIP3 regulates cleavage furrow ingression and abscission during cytokinesis." Simon G.C., Schonteich E., Wu C.C., Piekny A., Ekiert D., Yu X., Gould G.W., Glotzer M., Prekeris R. EMBO J. 27:1791-1803(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAB11FIP3. |
| [22] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203; SER-206; SER-257; THR-342; THR-580; THR-588; SER-600; THR-601 AND THR-606, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [23] | "Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells." Burkard M.E., Maciejowski J., Rodriguez-Bravo V., Repka M., Lowery D.M., Clauser K.R., Zhang C., Shokat K.M., Carr S.A., Yaffe M.B., Jallepalli P.V. PLoS Biol. 7:E1000111-E1000111(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION AT SER-157; SER-164; SER-170; SER-214 AND THR-260, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-157; SER-164; SER-170 AND SER-214. |
| [24] | "Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation." Wolfe B.A., Takaki T., Petronczki M., Glotzer M. PLoS Biol. 7:E1000110-E1000110(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ECT2, PHOSPHORYLATION AT SER-149; SER-157; SER-164 AND SER-170, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-149; SER-157; SER-164 AND SER-170. |
| [25] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-157; SER-203 AND SER-206, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [26] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-157; SER-203; THR-342; THR-567 AND THR-588, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [27] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [28] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND SER-157, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB030251 mRNA. Translation: BAA90247.1. AL136794 mRNA. Translation: CAB66728.1. AK000733 mRNA. Translation: BAA91347.1. CR533565 mRNA. Translation: CAG38596.1. BC024144 mRNA. Translation: AAH24144.1. Frameshift. BC032754 mRNA. Translation: AAH32754.1. AB040911 mRNA. Translation: BAA96002.1. | ||||||||||||||||||
| IPI | IPI00152946. | ||||||||||||||||||
| PIR | D59430. | ||||||||||||||||||
| RefSeq | NP_001119575.1. NM_001126103.1. NP_001119576.1. NM_001126104.1. NP_037409.2. NM_013277.3. | ||||||||||||||||||
| UniGene | Hs.505469. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q9H0H5. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-33087N. | ||||||||||||||||||
| IntAct | Q9H0H5. 12 interactions. | ||||||||||||||||||
| MINT | MINT-256435. | ||||||||||||||||||
| STRING | 9606.ENSP00000309871. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9H0H5. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 74762727. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q9H0H5. | ||||||||||||||||||
| PeptideAtlas | Q9H0H5. | ||||||||||||||||||
| PRIDE | Q9H0H5. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 29127. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000312377; ENSP00000309871; ENSG00000161800. ENST00000427314; ENSP00000404190; ENSG00000161800. ENST00000434422; ENSP00000413241; ENSG00000161800. ENST00000454520; ENSP00000404808; ENSG00000161800. ENST00000547905; ENSP00000449370; ENSG00000161800. ENST00000551016; ENSP00000449374; ENSG00000161800. | ||||||||||||||||||
| GeneID | 29127. | ||||||||||||||||||
| KEGG | hsa:29127. | ||||||||||||||||||
| UCSC | uc001rvs.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 29127. | ||||||||||||||||||
| GeneCards | GC12M050370. | ||||||||||||||||||
| H-InvDB | HIX0036723. | ||||||||||||||||||
| HGNC | HGNC:9804. RACGAP1. | ||||||||||||||||||
| HPA | CAB025859. HPA043912. | ||||||||||||||||||
| MIM | 604980. gene. | ||||||||||||||||||
| neXtProt | NX_Q9H0H5. | ||||||||||||||||||
| PharmGKB | PA34165. | ||||||||||||||||||
| HUGE | Search... | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG305341. | ||||||||||||||||||
| HOGENOM | HOG000230702. | ||||||||||||||||||
| HOVERGEN | HBG062009. | ||||||||||||||||||
| InParanoid | Q9H0H5. | ||||||||||||||||||
| KO | K16733. | ||||||||||||||||||
| OMA | CIPTLIG. | ||||||||||||||||||
| OrthoDB | EOG4CRKZM. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | aurora_b_pathway. Aurora B signaling. | ||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. REACT_604. Hemostasis. REACT_6900. Immune System. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9H0H5. | ||||||||||||||||||
| Bgee | Q9H0H5. | ||||||||||||||||||
| CleanEx | HS_RACGAP1. | ||||||||||||||||||
| Genevestigator | Q9H0H5. | ||||||||||||||||||
| GermOnline | ENSG00000161800. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.10.555.10. 1 hit. | ||||||||||||||||||
| InterPro | IPR002219. Prot_Kinase_C-like_PE/DAG-bd. IPR008936. Rho_GTPase_activation_prot. IPR000198. RhoGAP_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF00130. C1_1. 1 hit. PF00620. RhoGAP. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00109. C1. 1 hit. SM00324. RhoGAP. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF48350. Rho_GAP. 1 hit. | ||||||||||||||||||
| PROSITE | PS50238. RHOGAP. 1 hit. PS00479. ZF_DAG_PE_1. 1 hit. PS50081. ZF_DAG_PE_2. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| EvolutionaryTrace | Q9H0H5. | ||||||||||||||||||
| GenomeRNAi | 29127. | ||||||||||||||||||
| NextBio | 52240. | ||||||||||||||||||
| PMAP-CutDB | Q9H0H5. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | RGAP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9H0H5 Secondary accession number(s): Q6PJ26 Q9P2W2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
